Related Experiment Video
Updated: Oct 16, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
COVID and Lung Cancer.
Luana Calabrò1,2, Giulia Rossi3, Alessia Covre3,4,5
1Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy. l.calabro@ao-siena.toscana.it.
The COVID-19 pandemic has increased risks for lung cancer patients, complicating their care and treatment. This review examines the pandemic's impact and challenges in managing lung cancer during this era.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) poses a significant global health threat.
- Cancer patients, particularly those with lung cancer, face heightened susceptibility and mortality risks.
- The pandemic necessitated urgent reorganization of clinical activities, impacting cancer care delivery.
Purpose of the Study:
- To critically review the profound impact of the COVID-19 pandemic on lung cancer patients.
- To identify the significant challenges faced by oncologists in managing lung cancer during the pandemic.
- To discuss strategies for maintaining high standards of care for lung cancer patients amidst the pandemic.
Main Methods:
- Literature review and critical analysis of existing evidence.
- Synthesis of data on COVID-19's impact on lung cancer patient outcomes.
- Examination of clinical management adaptations and recommendations.
Main Results:
- Lung cancer patients exhibit increased susceptibility and mortality from COVID-19.
- Management challenges include potential drug interactions and differentiating COVID-19 pneumonitis from drug-induced pneumonitis.
- The pandemic has led to significant reshaping of oncological activities and treatment prioritization.
Conclusions:
- The COVID-19 pandemic presents unique and severe challenges for lung cancer patient management.
- Oncologists must navigate complex treatment decisions and diagnostic uncertainties.
- Developing and implementing evidence-based recommendations is crucial for optimizing care during health crises.
More Related Videos
Related Concept Videos
Other Pulmonary Disorders
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Statistical Methods for Analyzing Epidemiological Data
Cancer Prevention
Some...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

